Showing 172 results

Filters Content type: News, Editors' picks Topic: Injectable & long-acting PrEP

The antiretroviral drug cabotegavir, administered every eight weeks as an injection, has been shown to be safe and effective in preventing HIV infection in men who have sex with men. Studies in women are ongoing and scientists are also working on a long-acting PrEP implant.

Going Long

Editor's pick
POZ
26 June 2023

Uganda moves forward on PrEP vaginal ring and injection

Editor's pick
Be In The Know
20 December 2022